Navigation Links
New Data Analyses on CONCERTA® Pediatric Treatment Include Insight on Handwriting Performance and Attention in ADHD
Date:10/29/2010

NEW YORK, Oct. 29 /PRNewswire/ -- Data presented today at a major medical meeting include findings that demonstrate improved handwriting performance in children with Attention Deficit Hyperactivity Disorder (ADHD) when taking CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) compared to placebo. This data, which was presented by McNeil Pediatrics™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is one of two sub-analyses presented today on pooled data from two randomized, double-blind, placebo-controlled studies examining CONCERTA® efficacy in patients in simulated classroom environments.

(Logo: http://photos.prnewswire.com/prnh/20091104/CG04247LOGO-a)

(Logo: http://www.newscom.com/cgi-bin/prnh/20091104/CG04247LOGO-a)

(Logo: http://photos.prnewswire.com/prnh/20091104/CG04247LOGO-b)

(Logo: http://www.newscom.com/cgi-bin/prnh/20091104/CG04247LOGO-b)

"Previous research suggests handwriting can be a challenge in children with ADHD, who may have impaired handwriting performance compared to children without ADHD,(1,2,3)" said H. Lynn Starr, M.D., director of Medical Affairs for Ortho-McNeil Janssen Scientific Affairs, L.L.C. "Based on this premise, we wanted to examine CONCERTA® treatment in this area more closely. We hope our efforts may provide insight for parents and healthcare professionals interested in this research."

In this sub-analysis (Poster 5.26), the effect of CONCERTA® on handwriting performance was evaluated in 139 patients with ADHD, ages 9 to 12, in simulated classroom settings that compared patients' handwriting skills when they were treated with CONCERTA® versus wh
'/>"/>

SOURCE McNeil Pediatrics(TM)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress
2. Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses
3. The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports
4. Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
5. Results and Additional Analyses From Study Show That Cortheras Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables
6. Results and Additional Analyses From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
7. New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes
8. Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
9. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
10. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015  On August 5, 2015, the ... Oregon denied motions to dismiss securities class ... ) and certain of its directors. The class actions ... and dump" scheme to artificially inflate Galena,s stock price, ... stock price was inflated, sold massive amounts of their ...
(Date:8/31/2015)... , Aug. 31, 2015  Regulatory affairs ... government, where regulations are often strict and legislation ... driving a demand for professionals who have a ... regulations across a product lifecycle and demonstrate its ... University of California, Irvine Extension , in ...
(Date:8/31/2015)... SAN DIEGO , Aug. 31, 2015 ... announced today development of a novel means of ... nucleic acid, RGBP-248, to liver tumors utilizing a ... in development overcomes previous hurdles with gene silencing ... to be delivered throughout the whole body.  By ...
Breaking Medicine Technology:Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ... that Acetadote® ( acetylcysteine ) Injection, an injectable product ... available in the Australian market. Phebra Pty Ltd., an ... U.S.-based Cumberland Pharmaceuticals to market and distribute the product ...
... Biotechnology Corporation (Nasdaq: GNBT ) ( www.generex.com ) ... reverse stock split proposal put forward at the Annual Meeting ... DO NOT COUNT as votes cast in respect of ... Special Meeting of stockholders scheduled for 10 a.m. EDT on ...
Cached Medicine Technology:Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 2Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 3Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 4Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 5Generex Provides Clarification for Special Meeting Voting 2Generex Provides Clarification for Special Meeting Voting 3
(Date:8/31/2015)... , ... August 31, 2015 , ... Coast Dental ... September 5, 2015, from 11 a.m. to 3 p.m. near Albertsons in the Foothill ... opportunity to meet Dr. Ofelia Rivera and Dr. Jay Lopp. Call (760) 208-2518 for ...
(Date:8/31/2015)... ... 2015 , ... Neuropsychiatric Disease and Treatment has ... near-infrared laser phototherapy ”. , As corresponding author Dr Theodore Henderson says “These ... with mostly palliative treatments only - and now we have shown real clinical ...
(Date:8/31/2015)... Scotch Plains, NJ (PRWEB) , ... August 31, 2015 , ... NJ Top Docs Presents, ... Doc”!, Born and raised in Park Ridge, New Jersey, Dr. Michael Betsy graduated from Don ... and ice hockey and served as team captain in both sports in his senior year. ...
(Date:8/31/2015)... ... August 31, 2015 , ... How ... and others—to hold down costs? , In a commentary for The American ... presents the concept of “clinical efficacy,” which would bind parties together in agreements ...
(Date:8/31/2015)... ... August 31, 2015 , ... The dental implant and prosthetic market ... Academy of Implant Dentistry. (See Press Room ) More than 30 million Americans ... procedure. With the increasing demand for dental implants, the National Association of Dental Laboratories ...
Breaking Medicine News(10 mins):Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 2Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 3Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4
... March 14 Sergeant,s Pet Care Products,today ... division of Virbac,Corporation. The brands and technology ... that include internal and external health care,products, ... Well recognized,brands include WormXPlus(TM), WormX(R), Petrodex(R), Zema(R), ...
... Ky. (Mar. 14, 2008) − Transcendental Meditation is ... with the added benefit of bypassing possible side ... a new meta-analysis conducted at the University of ... of the American Journal of Hypertension. , The ...
... the laboratory suggests that a new compound can point the ... latent form of the bacterium, says a team led by ... A drug with such properties could also be useful in ... treatment period. The discovery also points to new ways of ...
... at The University of Nottingham say modern matrons ... to fulfil their role as leader, and this remains ... healthcare. , Researchers at the Institute for Science and ... and unless significant budgetary responsibility is made part of ...
... ... Awareness Month, LOS ANGELES, March 14 Award-winning singer ... Valvo, who,is a colon cancer survivor, appear in a new ... The PSAs also note that,with advances in treatment, more people ...
... Serwik to Visit Washington, D.C., and Meet with Elected ... Del. will travel to Washington, D.C., this April 1 ... restoration of the,Americans with Disabilities Act, support for epilepsy ... epilepsy., Serwik, 7, is one of 50 young ...
Cached Medicine News:Health News:Sergeant's(R) Pet Care Products Acquires the Consumer Brand Division of Virbac Corporation 2Health News:New chemical can kill latent tuberculosis bacteria 2Health News:New chemical can kill latent tuberculosis bacteria 3Health News:Modern matron struggling to fulfil role as leader 2Health News:Vanessa Williams and Carmen Marc Valvo Make It Fashionable to Talk About Colon Cancer In New Public Service Announcement 2Health News:Vanessa Williams and Carmen Marc Valvo Make It Fashionable to Talk About Colon Cancer In New Public Service Announcement 3Health News:Delaware Youth Named National Epilepsy Spokesperson 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: